Ursolic Acid Monotherapy Prolongs Cardiac Allograft Survival in Mice

Yong LIU,Yao LI,Chao LI,Xia HUANG,Chengbiao XUE,Xinpeng HU,Tao YANG,Ping ZHOU

DOI: https://doi.org/10.14188/j.1671-8852.2011.01.016

2011-01-01

Abstract:Objective: To investigate the effect of ursolic acid on cardiac allograft survival in mice. Methods: B6mice T cells were stimulated by anti-CD3 and anti-CD28 monoclonal antibody with or without ursolic acid. NF-κB P65 activity was detected 24 hours later. The frequency of CD25 and CD69 on T cell surface was also detected 48 hours later. The murine cardiac transplant model from BALB/c (H-2d) to C57BL/6 (H-2b) was built. The recipients were administered with or without different dosages of ursolic acid. The survival of cardiac grafts was observed. Histology and immunohistochemistry were performed to estimate the severity of rejection. Cytokine profile of lymphocytes was analyzed by real time PCR. Results: Ursolic acid dose-dependently inhibited TCR-triggered NF-κB nuclear translocation. The frequency of CD25 and CD69 was significantly downregulated by 25 μmol/L urolic acid (P0.05,vs vehicle control). For ursolic acid treatment group (10 mg/\[kg\5d\]), the median survival time (MST) of cardiac allografts was 23.8±1.3 days, which was significantly longer than the vehicle control group (P0.05, MST=7.4±0.5 d). Furthermore, ursolic acid at dosage of 30 mg/(kg\5d) prolonged MST to 68.5±2.8 days. The prolonged survival was associated with reduced infiltration of CD4 and CD8 lymphocytes in allografts. Furthermore, the intragraft transcriptional profiling in ursolic acid-treated group showed reduction IFN-γ mRNA but unaltered IL-4 mRNA. Conclusion: Ursolic acid inhibites NF-κB activation of T cell. Ursolic acid monotherapy could significantly prolong the survival of cardiac allograft in mice. This may relate to its suppression of T cell activation and induction of Th1/Th2 bias.